FDA applicant

Target Therapeutics

Freemont, CA70 decisions1985–19982 recalls

FDA records 70 decisions for Target Therapeutics (Freemont, CA) from 1985 to 1998: 70 510(k) clearances. Most are in product codes DQX (Wire, Guide, Catheter) and DQY (Catheter, Percutaneous). Its devices cite 33 predicates, 27 of them its own earlier devices. 2 recalls are linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, cardiovascular panel, where it files most

How often FDA has decided Target Therapeutics’s devices, and how often a recall has named them.

FDA decisions per year

No FDA decision for Target Therapeutics since 2007.

Recalls per year

No recall linked to its devices since 2007.

FIG. 1 — Target Therapeutics by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Target Therapeutics’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Other applicant names beginning “Target”

FDA records each applicant name separately; these may or may not be the same firm.

Target Health, Inc. 3 Target USA, Inc. 1

Target Therapeutics

Which product codes does it file in?

Whose devices does it build on?

Who builds on its devices?

Which of its devices are cited most?

What has FDA decided for it lately?

What has been recalled?

Other applicant names beginning “Target”